HRTX
HERON THERAPEUTICS, INC. /DE/
Next earnings Aug 6, 2026 · consensus $0.01 EPS, $43.0M rev
Last earnings -21.0% on 2026-05-11
$0.43
▲ +3.51%$0.43▼ -78.33%
over 1Y
L $0.38EODHDH $2.23
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.5%
1W+11.9%
1M-50.9%
3M-45.6%
YTD-65.6%
1Y-78.3%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Revenue grew 7.4% YoY; but unprofitable (net margin -13.0%).
HERON THERAPEUTICS, INC. /DE/ shows $155M in FY2025 revenue (+7.4% YoY), a -13.0% net margin, and -140.9% ROE.
Sources: SEC EDGAR (CIK 0000818033, latest 10-Q filed 2026-05-11) · EODHD · as of 6/25/2026, 3:31:48 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.